← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Carmustine currently has availability issues reported in 4 European registers: Germany, Spain, Ireland, Sweden.
Shortage ATC L01AD01 · also listed as: Carmustin · CARMUSTINA · Carmustine · karmustin · data refreshed 10 September 2026
As of 10 September 2026, 4 of the 9 tracked registers list current availability issues for Carmustine, covering 5 affected product presentations. The longest-running open report was filed in Germany on 2026-01-05 and has now been open for about 8 months. Where agencies state a cause, manufacturing problems lead with 1 of the 2 stated-cause reports, followed by quality issues with 1. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-12-31. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Germany, Spain, Ireland, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Carmustine is coded L01AD01 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Carmustin-ratiopharm | 2026-01-05 | 2026-12-31 | Probleme in der Herstellung Alternatives: N/A | register ↗ |
| 🇪🇸 Spain | Shortage CARMUSTINA ACCORDPHARMA 300 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial polvo + 1 vial de disolvente de 9 ml + 1 more productsCARMUSTINA TEVA 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 100 mg + 3 ml de disolvente | 2026-01-21 | — | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇪 Ireland | Shortage Carmustine 100 mg powder and solvent for concentrate for solution for in | 2026-02-01 | 2026-06-30 | Quality issue (Multiple countries) Alternatives: Alternative(s) available — see the national register. | register ↗ |
| 🇸🇪 Sweden | Shortage Carmustine Accordpharma 300 mg Pulv. o vätska till konc. till inf.vätska, lösn. | 2026-01-08 | 2026-07-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Carmustine in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇪🇸 ES | CARMUSTINA ACCORDPHARMA 300 MG POLVO Y DISOLVENTE PARA CONCENTRADO PAR | Shortage | 2026-04-14 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇪 IE | Carmustine 100 mg powder and solvent for concentrate for solution for | Shortage | 2026-02-01 | 2026-06-30 | Quality issue (Multiple countries) |
| 🇪🇸 ES | CARMUSTINA TEVA 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCI | Shortage | 2026-01-21 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇸🇪 SE | Carmustine Accordpharma 300 mg Pulv. o vätska till konc. till inf.väts | Shortage | 2026-01-08 | 2026-07-31 | |
| 🇩🇪 DE | Carmustin-ratiopharm | Shortage | 2026-01-05 | 2026-12-31 | Probleme in der Herstellung |
Yes. As of 10 September 2026, availability issues are reported in: Germany, Spain, Ireland, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-12-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Carmustine: BfArM (Germany), AEMPS CIMA (Spain), HPRA (Ireland), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Carmustine — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/carmustine/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Carmustine availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/carmustine/">Carmustine shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>